31.12.2012 Views

Bulletin 2012/02 - European Patent Office

Bulletin 2012/02 - European Patent Office

Bulletin 2012/02 - European Patent Office

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(A61K) II.1(1)<br />

(21) 05738545.2 (22) 27.04.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU MC NL PL PT RO SE<br />

SI SK TR<br />

AL BA HR LV MK YU<br />

(43) 14.<strong>02</strong>.2007<br />

(86) JP 2005/008450 27.04.2005<br />

(87) WO 2005/105086 2005/45 10.11.2005<br />

(30) 29.04.2004 US 566180 P<br />

(54) • VERFAHREN ZUR VERRINGERUNG DER<br />

GASTROINTESTINALEN TOXIZITÄT<br />

DURCH VERABREICHUNG VON TEGAFUR<br />

• METHOD FOR REDUCING GASTROIN-<br />

TESTINAL TOXICITY DUE TO THE<br />

ADMINISTRATION OF TEGAFUR<br />

• PROCÉDÉ SERVANT À RÉDUIRE LA<br />

TOXICITÉ GASTRO-INTESTINALE DUE À<br />

L'ADMINISTRATION DE TÉGAFUR<br />

(73) TAIHO PHARMACEUTICAL CO., LTD., 1-27,<br />

Kandanishiki-cho, Chiyoda-ku, Tokyo 101-<br />

0054, JP<br />

(72) TAHARA, Takeshi, Yokohama-shi, Kanagawa<br />

2270047, JP<br />

AMBE, Hiroshi, Shinagawa-ku, Tokyo<br />

1400015, JP<br />

KURITANI, Jun, 229159, SG<br />

NOMURA, Naruo, DECEASED, JP<br />

(74) HOFFMANN EITLE, <strong>Patent</strong>- und Rechtsanwälte<br />

Arabellastraße 4, 81925 München, DE<br />

A61K 31/4439 → (51) C07D 401/06<br />

A61K 31/4525 → (51) C07D 401/12<br />

A61K 31/4535 → (51) C07D 401/12<br />

A61K 31/454 → (51) C07D 233/76<br />

A61K 31/454 → (51) C07D 401/12<br />

A61K 31/47 → (51) C07D 217/22<br />

A61K 31/4706 → (51) A61K 31/167<br />

A61K 31/472 → (51) C07D 217/24<br />

A61K 31/472 → (51) C07D 217/26<br />

A61K 31/4725 → (51) C07D 217/24<br />

A61K 31/4725 → (51) C07D 217/26<br />

A61K 31/4745 → (51) C07D 217/24<br />

A61K 31/495 → (51) C07D 295/08<br />

(51) A61K 31/496 (11) 2 066 325 B1<br />

A61K 9/22<br />

(25) En (26) En<br />

(21) 07823939.9 (22) 26.09.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

(43) 10.06.2009<br />

(86) GB 2007/003677 26.09.2007<br />

(87) WO 2008/038003 2008/14 03.04.2008<br />

(30) 26.09.2006 GB 0618879<br />

(54) • PHARMAZEUTISCHE ARIPIPRAZOL-<br />

ZUSAMMENSETZUNGEN<br />

• PHARMACEUTICAL COMPOSITIONS OF<br />

ARIPIPRAZOLE<br />

• COMPOSITIONS PHARMACEUTIQUES<br />

D'ARIPIPRAZOLE<br />

(73) Zysis Limited, 10 Glebe Street, Beeston<br />

Nottingham NG9 1BZ, GB<br />

(72) WILDING, Ian, Nottingham NG9 1BZ, GB<br />

PENDLETON, Russell, London SW14 7HW,<br />

GB<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(74) Crowhurst, Charlotte Waveney, Potter Clarkson<br />

LLP Park View House 58 The Ropewalk,<br />

Nottingham NG1 5DD, GB<br />

A61K 31/496 → (51) C07D 217/24<br />

(51) A61K 31/497 (11) 2 037 928 B1<br />

A61P 9/10 A61P 25/28<br />

A61P 9/12 A61P 3/00<br />

A61P 3/06<br />

(25) En (26) En<br />

(21) 07796488.0 (22) 26.06.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(43) 25.03.2009<br />

(86) US 2007/014873 26.06.2007<br />

(87) WO 2008/0<strong>02</strong>591 2008/01 03.01.2008<br />

(30) 26.06.2006 US 816415 P<br />

(54) • VERFAHREN ZUR BEHANDLUNG VON<br />

ATHEROSKLEROSE<br />

• METHODS FOR TREATING ATHERO-<br />

SCLEROSIS<br />

• PROCÉDÉS DE TRAITEMENT DE L'ATHÉ-<br />

ROSCLÉROSE<br />

(73) Amgen Inc., One Amgen Center Drive,<br />

Thousand Oaks, CA 91320-1799, US<br />

(72) KAYSER, Frank, San Francisco, CA 94114,<br />

US<br />

LABELLE, Marc, Chatham, NJ 07928, US<br />

SHAN, Bei, Redwood City, CA 94065, US<br />

ZHANG, Jian, Foster City, CA 94404, US<br />

ZHOU, Mingyue, El Cerrito, CA 94530, US<br />

(74) Grünecker, Kinkeldey, Stockmair & Schwanhäusser,<br />

Anwaltssozietät Leopoldstrasse 4,<br />

808<strong>02</strong> München, DE<br />

(60) 11008409.2<br />

A61K 31/4985 → (51) C07D 487/04<br />

A61K 31/506 → (51) C07D 239/32<br />

A61K 31/506 → (51) C07D 401/12<br />

A61K 31/513 → (51) A61K 31/4412<br />

A61K 31/517 → (51) A61K 31/167<br />

A61K 31/517 → (51) C07D 239/88<br />

A61K 31/517 → (51) C07D 239/90<br />

A61K 31/519 → (51) A61K 31/00<br />

A61K 31/519 → (51) C07D 475/08<br />

A61K 31/519 → (51) C07D 487/04<br />

(51) A61K 31/53 (11) 1 971 339 B1<br />

A61K 31/64 A61P 3/10<br />

(25) En (26) En<br />

(21) 06829703.5 (22) 18.12.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

(43) 24.09.2008<br />

(86) EP 2006/012182 18.12.2006<br />

(87) WO 2007/079914 2007/29 19.07.2007<br />

(30) 13.01.2006 FR 0600342<br />

(54) • KOMBINATION VON TRIAZIN-DERIVATEN<br />

UND INSULIN-SEKRETIONSSTIMULATO-<br />

REN<br />

• COMBINATION OF TRIAZINE DERIVATIVES<br />

AND INSULIN SECRETION STIMULATORS<br />

• COMBINAISON DE DERIVES DE TRIAZINE<br />

ET DE STIMULATEURS DE SECRETION<br />

D'INSULINE<br />

521<br />

<strong>Patent</strong>e<br />

<strong>Patent</strong>s<br />

Brevets (<strong>02</strong>/<strong>2012</strong>) 11.01.<strong>2012</strong><br />

(73) POXEL SAS, 200 Avenue Jean Jaures, 69007<br />

Lyon, FR<br />

(72) MOINET, Gérard, F-91400 Orsay, FR<br />

CRAVO, Daniel, F-78500 Sartrouville, FR<br />

MESANGEAU, Didier, F-77380 Combs-la-<br />

Ville, FR<br />

(74) Tezier Herman, Béatrice, et al, Cabinet Becker<br />

& Associés 25, rue Louis Le Grand, 750<strong>02</strong><br />

Paris, FR<br />

A61K 31/53 → (51) A61K 31/4412<br />

A61K 31/536 → (51) C07D 265/36<br />

A61K 31/5377 → (51) C07D 217/24<br />

A61K 31/538 → (51) C07D 209/82<br />

A61K 31/5415 → (51) C07D 209/82<br />

A61K 31/55 → (51) C07D 209/82<br />

A61K 31/553 → (51) C07D 498/08<br />

A61K 31/64 → (51) A61K 31/53<br />

A61K 31/70 → (51) C12N 15/63<br />

A61K 31/7076 → (51) A61K 31/00<br />

(51) A61K 31/7088 (11) 1 807 094 B1<br />

A61K 31/7125<br />

(25) En (26) En<br />

(21) 05820420.7 (22) 04.11.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

(43) 18.07.2007<br />

(86) KR 2005/003717 04.11.2005<br />

(87) WO 2006/049454 2006/19 11.05.2006<br />

(30) 05.11.2004 KR 20040090000<br />

(54) • THERAPEUTISCHE VERWENDUNG VON<br />

CPG-OLIGODEOXYNUKLEOTID BEI HAUT-<br />

KRANKHEITEN<br />

• THERAPEUTIC USE OF CPG OLIGODEOX-<br />

YNUCLEOTIDE FOR SKIN DISEASE<br />

• UTILISATION THERAPEUTIQUE D'OLIGO-<br />

DESOXYNUCLEOTIDE CPG POUR MALA-<br />

DIES DE LA PEAU<br />

(73) Bio Clue & Solution Co., Ltd., Dermato-<br />

Immunology Lab. Nr.4003, Catholic Res.<br />

Insti. of Medical Science Catholic Uni.<br />

Medical College, 505 Banpo-dong, Seochogu,<br />

Seoul 137-040, KR<br />

Kim, Tae-Yoon, 8-7<strong>02</strong>, Asia-Seonsuchon<br />

Apartment, Chamsil-dong, Songpa-ku, 138-<br />

220 Seoul, KR<br />

Shin, Dong-Heon, Shindonga Apt. 3-1305<br />

Seobing-dong, Yongsan-gu, Seoul 140-751,<br />

KR<br />

(72) KIM, Doo-Sik, Seoul 120-824, KR<br />

KWON, Hyung-Joo, Cheongju, Chungcheongbuk-do<br />

360-770, KR<br />

KIM, Yang-Soon, Seoul 137-809, KR<br />

KIM, Tae-Yoon, Seoul 138-220, KR<br />

SHIN, Dong-Heon, Seoul 140-751, KR<br />

(74) Luderschmidt, Wolfgang, Luderschmidt,<br />

Schüler & Partner <strong>Patent</strong>anwälte John-F.-<br />

Kennedy-Strasse 4, 65189 Wiesbaden, DE<br />

A61K 31/7125 → (51) A61K 31/7088<br />

A61K 31/713 → (51) C12N 15/117<br />

(51) A61K 31/715 (11) 1 911 454 B1<br />

A61K 31/192 A61P 15/<strong>02</strong><br />

(25) Zh (26) En<br />

(21) 06741747.7 (22) 27.04.2006

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!